---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-108439"
form_type: "8-K"
ticker: "LYRA"
cik: "0001327273"
company_name: "Lyra Therapeutics, Inc."
filed_at: "2026-03-16T23:59:59+00:00"
generated_at: "2026-05-15T11:27:07.007241+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Lyra Therapeutics to suspend trading on Nasdaq March 17 after delisting appeal withdrawal

## Summary
- Company withdrew appeal of February 2, 2026 Nasdaq delisting determination.
- Nasdaq confirmed suspension of common stock trading at open on March 17, 2026.
- Nasdaq will file Form 25 with SEC after internal procedural periods elapse.
- No trading halt or additional compliance period cited; delisting is final.

## SEC filing metadata
- accession: 0001193125-26-108439
- form_type: 8-K
- ticker: LYRA
- cik: 0001327273
- company_name: Lyra Therapeutics, Inc.
- filed_at: 2026-03-16T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1327273/000119312526108439/0001193125-26-108439-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1327273/000119312526108439/d55950d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-108439
- JSON: https://secwatch.observer/filing/0001193125-26-108439.json
- Plain text: https://secwatch.observer/filing/0001193125-26-108439.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.